Patents by Inventor Patrick BAUM

Patrick BAUM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF BIOMARKERS IN THE TREATMENT OF FIBROTIC CONDITIONS
    Publication number: 20230135671
    Abstract: Genes selected from CEACAM6, CEACAM8, CTSG, DEFA4, LTF, MMP8, OLFM4, OLR1, SHISA4, ABCA13, EMID1, LMOD1, MPO, and PRTN3 can be used as biomarkers in methods for the treatment of progressive fibrosing interstitial lung diseases.
    Type: Application
    Filed: March 30, 2021
    Publication date: May 4, 2023
    Inventors: Benjamin STROBEL, Patrick BAUM, Claudia DIEFENBACH
  • ANTI-IL-36R ANTIBODIES FOR TREATMENT OF PALMOPLANTAR PUSTULOSIS
    Publication number: 20230131364
    Abstract: The present invention relates to the treatment of or alleviation of signs and symptoms of palmoplantar pustulosis (PPP) with anti-IL-36R antibodies in a patient.
    Type: Application
    Filed: August 10, 2022
    Publication date: April 27, 2023
    Inventors: Patrick BAUM, Janine LAMAR, Steven John PADULA, Christian THOMA
  • ANTI-IL-36R ANTIBODIES FOR TREATMENT OF PALMOPLANTAR PUSTULOSIS
    Publication number: 20230115617
    Abstract: The present invention relates to the treatment of or alleviation of signs and symptoms of palmoplantar pustulosis (PPP) with anti-IL-36R antibodies in a patient.
    Type: Application
    Filed: November 10, 2022
    Publication date: April 13, 2023
    Inventors: Patrick BAUM, Janine LAMAR, Steven John PADULA, Christian THOMA
  • BIOMARKERS ASSOCIATED WITH ANTI-IL-36R ANTIBODY TREATMENT IN GENERALIZED PUSTULAR PSORIASIS
    Publication number: 20220290239
    Abstract: This invention generally relates to biomarkers associated with anti-IL-36R antibody treatment in generalized pustular psoriasis (GPP). The invention also relates to methods of using the biomarkers disclosed.
    Type: Application
    Filed: March 10, 2022
    Publication date: September 15, 2022
    Inventors: Patrick BAUM, Ahmed Karim FARAG, Sudha VISVANATHAN
  • BIOMARKERS USEFUL IN THE TREATMENT OF IL-23A RELATED DISEASES
    Publication number: 20200376117
    Abstract: This invention generally relates to biomarkers useful in the treatment of IL-23 related diseases, in particular inflammatory diseases such as psoriasis. The invention also relates to methods of using the biomarkers disclosed herein, for example in therapies utilizing IL-23 antagonists.
    Type: Application
    Filed: December 10, 2019
    Publication date: December 3, 2020
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Sudha Visvanathan, Patrick Baum, Oliver Kleiner, Ulrich Kunz
  • METHODS OF TREATING INFLAMMATORY DISEASES
    Publication number: 20200308271
    Abstract: This invention generally relates to methods for the treatment of IL-23 related diseases, in particular inflammatory diseases, such as psoriasis or psoriatic arthritis, utilizing anti-IL-23A antibodies.
    Type: Application
    Filed: December 21, 2019
    Publication date: October 1, 2020
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Patrick BAUM, Mary Ruth Flack, Annette Bettina Galler, Bojan Lalovic, Kaori Maino, Steven John Padula, Paul Scholl, Koji Sha, Sudha Visvanathan
  • METHODS OF TREATING DISEASES
    Publication number: 20200299378
    Abstract: This invention generally relates to methods for the treatment of IL-23 related diseases, in particular inflammatory diseases, such as Crohn's Disease, utilizing anti-IL-23A antibodies.
    Type: Application
    Filed: December 13, 2019
    Publication date: September 24, 2020
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Patrick BAUM, Wulf Otto BOECHER, Annette Bettina GALLER, Bojan LALOVIC, Sudha VISVANATHAN
  • ANTI-IL-36R ANTIBODIES FOR TREATMENT OF PALMOPLANTAR PUSTULOSIS
    Publication number: 20200207862
    Abstract: The present invention relates to the treatment of or alleviation of signs and symptoms of palmoplantar pustulosis (PPP) with anti-IL-36R antibodies in a patient.
    Type: Application
    Filed: December 20, 2019
    Publication date: July 2, 2020
    Inventors: Patrick BAUM, Janine LAMAR, Steven John PADULA, Christian THOMA
  • Biomarkers useful in the treatment of IL-23A related diseases
    Patent number: 10507241
    Abstract: This invention generally relates to biomarkers useful in the treatment of IL-23 related diseases, in particular inflammatory diseases such as psoriasis. The invention also relates to methods of using the biomarkers disclosed herein, for example in therapies utilizing IL-23 antagonists.
    Type: Grant
    Filed: July 23, 2015
    Date of Patent: December 17, 2019
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Sudha Visvanathan, Patrick Baum, Oliver Kleiner, Ulrich Kunz
  • METHODS OF TREATING DISEASES
    Publication number: 20180105588
    Abstract: This invention generally relates to methods for the treatment of IL-23 related diseases, in particular inflammatory diseases, such as Crohn's Disease, utilizing anti-IL-23A antibodies.
    Type: Application
    Filed: October 11, 2017
    Publication date: April 19, 2018
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Patrick Baum, Wulf Otto Boecher, Annette Bettina Galler, Bojan Lalovic, Sudha Visvanathan
  • METHODS OF TREATING INFLAMMATORY DISEASES
    Publication number: 20170298126
    Abstract: This invention generally relates to methods for the treatment of IL-23 related diseases, in particular inflammatory diseases, such as psoriasis or psoriatic arthritis, utilizing anti-IL-23A antibodies.
    Type: Application
    Filed: April 13, 2017
    Publication date: October 19, 2017
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Patrick BAUM, Mary Ruth FLACK, Annette Bettina GALLER, Bojan LALOVIC, Kaori MAINO, Steven John PADULA, Paul SCHOLL, Koji SHA, Sudha VISVANATHAN
  • BIOMARKERS USEFUL IN THE TREATMENT OF IL-23A RELATED DISEASES
    Publication number: 20170157246
    Abstract: This invention generally relates to biomarkers useful in the treatment of IL-23 related diseases, in particular inflammatory diseases such as psoriasis. The invention also relates to methods of using the biomarkers disclosed herein, for example in therapies utilizing IL-23 antagonists.
    Type: Application
    Filed: July 23, 2015
    Publication date: June 8, 2017
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Sudha Visvanathan, Patrick BAUM, Oliver KLEINER, Ulrich KUNZ